The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...

Francesco Cacciatore is a self-proclaimed skeptic. Yet after spending two decades in the European aerospace industry and hitting, as he put it, a “crisis,” he made an undeniably optimistic bet: He ...

Orbital Paradigm’s KID capsule is being prepared for a test flight before the end of 2025. Credit: Orbital Paradigm WASHINGTON — A Spanish startup is entering the emerging reentry vehicle market with ...

Payments giant Stripe and crypto investment firm Paradigm on Thursday officially unveiled Tempo, their joint blockchain project designed for stablecoin payments. The initiative, incubated inside ...

Stripe is funding a new blockchain company called Tempo, co-founder CEO Patrick Collison announced on Thursday. Tempo is aimed at high-volume processing of stablecoins — coins that help reduce ...

Most RVs are there for use every once in a while, but others, others are on a whole different level. One fifth-wheel that belongs to the latter category is the 2026 Paradigm 395DS, a mobile habitat ...

Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less than the upper limit of normal) at the ...

Larry Ellison, Oracle's co-founder, has surpassed Elon Musk to become the world's richest person in 2025. Oracle's stock soared after a record-breaking earnings report, increasing Ellison's net worth ...

The Goods and Services Tax (GST) Council, during its 56th meeting, decided to revamp the tax structure into a primarily two-rate system as proposed by the Central government, Union Finance Minister ...

Two of Silicon Valley’s top tech firms are teaming up to change the payments landscape. On Thursday, the $91.5 billion fintech Stripe and the crypto venture firm Paradigm publicly announced their ...

Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent ...